Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients

References

• Davidson A, Gelmon K. Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?. Future Oncol 2011; 7:37 - 55; PMID: 21174537; http://dx.doi.org/10.2217/fon.10.163
   PubMed Web of Science ®Google Scholar
• Blakey JD, Hall IP. Current progress in pharmacogenetics. Br J Clin Pharmacol 2011; 71:824 - 831; PMID: 21235621; http://dx.doi.org/10.1111/j.1365-2125.2011.03912.x
   PubMed Web of Science ®Google Scholar
• Lee W, Lockhart AC, Kim RB, Rothenberg ML. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. Oncologist 2005; 10:104 - 111; PMID: 15709212; http://dx.doi.org/10.1634/theoncologist.10-2-104
   PubMed Web of Science ®Google Scholar
• Ambrosone CB, Ahn J, Singh KK, Rezaishiraz H, Furberg H, Sweeney C, et al. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 2005; 65:1105 - 1111; PMID: 15705913
   PubMed Web of Science ®Google Scholar
• Bewick MA, Conlon MSC, Lafrenie RM. Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer. Breast Cancer Res Treat 2008; 111:93 - 101; PMID: 17922231; http://dx.doi.org/10.1007/s10549-007-9764-8
   PubMed Web of Science ®Google Scholar
• Suresh A, Guedez L, Moreb J, Zucali J. Overexpression of manganese superoxide dismutase promotes survival in cell lines after doxorubicin treatment. Br J Haematol 2003; 120:457 - 463; PMID: 12580960; http://dx.doi.org/10.1046/j.1365-2141.2003.04074.x
   PubMed Web of Science ®Google Scholar
• Sau A, Tregno FP, Valentino F, Federici G, Caccuri AM. Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 2010; 500:116 - 122; PMID: 20494652; http://dx.doi.org/10.1016/j.abb.2010.05.012
   PubMed Web of Science ®Google Scholar
• Arun BK, Granville LA, Yin G, Middleton LP, Dawood S, Kau SW, et al. Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Invest 2010; 28:554 - 559; PMID: 20210524; http://dx.doi.org/10.3109/07357900903286925
   PubMed Web of Science ®Google Scholar
• Hamidovic A, Hahn K, Kolesar J. Clinical Significance of ABCB1 Genotyping in Oncology. J Oncol Pharm Pract 2010; 16:39 - 44; PMID: 19401306; http://dx.doi.org/10.1177/1078155209104380
   PubMedGoogle Scholar
• Hoffimeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97:3473 - 3478; PMID: 10716719; http://dx.doi.org/10.1073/pnas.050585397
   PubMed Web of Science ®Google Scholar
• Pan JH, Han JX, Wu JM, Huang HN, Yu QZ, Sheng LJ. MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. Respiration 2009; 78:49 - 55; PMID: 18812689; http://dx.doi.org/10.1159/000158454
   PubMed Web of Science ®Google Scholar
• Ni LN, Li JY, Miao KR, Qiao C, Zhang SJ, Qiu HR, et al. Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia. Med Oncol 2011; 28:265 - 269; PMID: 20204543; http://dx.doi.org/10.1007/s12032-010-9456-9
   PubMed Web of Science ®Google Scholar
• Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis 2001; 22:827 - 829; PMID: 11323405; http://dx.doi.org/10.1093/carcin/22.5.827
   PubMed Web of Science ®Google Scholar
• Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, et al. A mitochondrial target sequence polymorphism in MnSOD predicts inferior survival in breast cancer patients treated with Cyclophosphamide. Clin Cancer Res 2009; 15:4165 - 4173; PMID: 19509150; http://dx.doi.org/10.1158/1078-0432.CCR-09-0119
   PubMed Web of Science ®Google Scholar
• Yang G, Shu XO, Ruan ZX, Cai QY, Jin F, Gao YT, et al. Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma. Cancer 2005; 103:52 - 58; PMID: 15565566; http://dx.doi.org/10.1002/cncr.20729
   PubMed Web of Science ®Google Scholar
• Sun N, Sun X, Chen B, Cheng H, Feng J, Cheng L, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 2010; 65:437 - 446; PMID: 19568750; http://dx.doi.org/10.1007/s00280-009-1046-1
   PubMed Web of Science ®Google Scholar
• Kadouri L, Kote-Jarai Z, Hubert A, Baras M, Abeliovich D, Hamburger T, et al. Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Br J Cancer 2008; 98:2006 - 2010; PMID: 18542066; http://dx.doi.org/10.1038/sj.bjc.6604394
   PubMed Web of Science ®Google Scholar
• Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao WD, Yu M, et al. Association between glutathione S-transferase P1, T1 and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 2002; 94:936 - 942; PMID: 12072547
   PubMed Web of Science ®Google Scholar
• Oliveira AL, Rodrigues FFO, Santos RE, Aoki T, Rocha MN, Longui CA, et al. GSTT1, GSTM1 and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Genet Mol Res 2010; 9:1045 - 1053; PMID: 20568049; http://dx.doi.org/10.4238/vol9-2gmr726
   PubMed Web of Science ®Google Scholar
• Alpert LC, Schecter RL, Berry DA, Melnychuk D, Peters WP, Caruso JA, et al. Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer. Clin Cancer Res 1997; 3:661 - 667; PMID: 9815734
   PubMed Web of Science ®Google Scholar
• Johnstone RW, Ruefli AA, Smyth MJ. Multiple physiological functions for multidrug transporter P-glycoprotein?. Trends Biochem Sci 2000; 25:1 - 6; PMID: 10637601; http://dx.doi.org/10.1016/S0968-0004(99)01493-0
   PubMed Web of Science ®Google Scholar
• Cizmarikova M, Wagnerova M, Schonova L, Habalova V, Kohut A, Linkova A, et al. MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J 2010; 10:62 - 69; PMID: 19752884; http://dx.doi.org/10.1038/tpj.2009.41
   PubMed Web of Science ®Google Scholar
• Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillnger R, et al. Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol 2003; 22:1117 - 1121; PMID: 12684679
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T, et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 2002; 71:297 - 303; PMID: 11956513; http://dx.doi.org/10.1067/mcp.2002.122055
   PubMed Web of Science ®Google Scholar
• Sohn JW, Lee SY, Lee SJ, Kim EJ, Cha SI, Kim CH, et al. MDR1 polymorphisms predict the response to Etoposide-Cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 2006; 36:137 - 141; PMID: 16478794; http://dx.doi.org/10.1093/jjco/hyi231
   PubMed Web of Science ®Google Scholar
• von Minckwitz G, Blohmer JU, Raab G, Lohr A, Gerber B, Heinrich G, et al. In vivo chemosensitivityadapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol 2005; 16:56 - 63; PMID: 15598939; http://dx.doi.org/10.1093/annonc/mdi001
   PubMed Web of Science ®Google Scholar
• von Minckwitz G, Kümmel S, Vogel P, Hanusch C, Eidtmann H, Hilfrich J, et al. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Cancer Inst 2008; 100:542 - 551; PMID: 18398097; http://dx.doi.org/10.1093/jnci/djn085
   PubMed Web of Science ®Google Scholar
• Tang JH, Zhao JH, Wu JZ, Lu JW, Pan LQ, Xu ZY. Multiplex ligation-dependent SNPs genotyping method and its application in the detection of genes related to chemotherapy drugs in breast cancer. Chin J Oncol 2009; 31:108 - 113
   Google Scholar
• Eggerding FA. Fluorescent oligonucleotide ligation technology for identification of ras oncogene mutations. Mol Biotechnol 2000; 14:223 - 233; PMID: 10890013; http://dx.doi.org/10.1385/MB:14:3:223
   PubMed Web of Science ®Google Scholar